Investigating Biofilm-Related Biomarkers to Predict Therapy Response in Colorectal Cancer Tumors: Year 2
ISEF · 2024 Translational Medical Science
Overview
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths. Often covered in biofilms, right sided tumors are deadly and often identified in advanced stages, highlighting the need to identify biofilm-related biomarkers related to CRC. Mucins, a type of biomarker, are upregulated in the presence of biofilms, proposing their use as a novel biomarker usable for predicting therapy response. For this project, a novel connection between mucin biomarkers and therapy responses of four categories of treatments was explored by (i) cleaning relevant CRC datasets (ii) identifying the relationship between mucin levels/ mutation rates and CRC subtypes and (iii) developing a novel model to predict therapy response from mucin biomarkers and patient demographics using a Random Forest Machine Learning Models with specialized hyperparameters and 10-fold cross validation. Datasets were first cleaned and preprocessed using PyJanitor, then 20% of the data was augmented and reconfirmed for cleanliness. Evaluation of the efficacy of specific mucin biomarkers were tested and resulted in an average accuracy of 0.81 when both MUC5B and MUC2 were used (AUC-ROC>0.75). Using the novel biomarkers, a Random Forest Classifier Machine Learning Model was developed, able to predict the therapy response (survival in months) of patients at 0.86 accuracy (AUC-ROC>0.85), suggesting the identification of novel biomarkers that can predict therapy responses for CRC patients. This model will continue to be trained with robust datasets to increase accuracy and efficacy. Future work includes experimentation with different optimization and regularization techniques to prevent any potential over and underfitting of data and delving into deep learning machine learning models
Competition history
- ISEF 2024
Resources
Related projects
ISEF · 2026
Spatial Analysis of Epithelial-to-Mesenchymal Transition Dynamics and Fusobacterium nucleatum Associations in Colorectal Cancer (Year 3)
ISEF · 2022
Novel Prediction of Five-Year Survival and Recurrence Rates and Discovery of Cancer Genetic Biomarkers Using MIBI Scans in the Tumor-Immune Microenvironment
ISEF · 2023
FadA-Secreting Fusobacterium nucleatum Promotes Inflammatory and Immunomodulatory Response in Colorectal Cancer (Year 2)
ISEF · 2021
A Novel Machine Learning Based Identification Tool (ELECT) for Early Colorectal Cancer Detection through Advanced Microbiome Composition Analysis
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair